The global leukapheresis market size is expected to reach USD 106.2 million by 2028 according to a new study by Polaris Market Research. The report “Leukapheresis Market Share, Size, Trends, Industry Analysis Report, By Application (Research, Therapeutics); By Type (Disposables, Devices); By End-Use; By Region; Segment Forecasts, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Leukapheresis is defined as the laboratory-based method in which white blood cells are separated from the blood sample. It is a type of apheresis procedure that involves separating one specific blood constituent and returning the remainder to the bloodstream. Previously, the leukapheresis method was designed for the palliative treatment of diseases such as leukemia with minimal efficacy. But later, it was also adopted for the treatment modality for hyperleukocytosis acute myeloid leukemia.
An increasing number of populations suffering from leukemia, rising blood donation centers, and government spending on improving the healthcare infrastructure along with R&D and clinical trials focused on leukocytes and CAR T cells to treat various other cancer types are key factors driving the market growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/leukapheresis-market/request-for-sample
The procedure removes WBCs, including leukemia, and returns the rest of the blood cell components into the circulatory system. Increasing incidence of leukemia and the surge in cases of associated disorders are likely to intensify the industry growth over the study period. The demand for this industry is projected to propel in the near future due to the rising research and development activities on leukocytes and increasing number of blood donations & surging demand for leukopaks.
Market participants such as AllCells, LLC, StemExpress, LLC., Haemonetics Corporation, Caltag Medsystems Limited, Lonza Group AG, ZenBio, Asahi Kasei Medical, Terumo BCT, Inc., Macopharma SA, Miltenyi Biotec, Fresenius SE & Co. KGaA, Guangzhou Daji Medical Science, MEDICA S.p.A, PuriBlood Medical Co. Ltd., and Beijing ZKSK Technology Co. Ltd.
Polaris Market Research has segmented the leukapheresis market report on the basis of type, application, end-use, and region:
Leukapheresis, Type Outlook (Revenue – USD Million, 2016 – 2028)
- Apheresis Devices
- Columns & Cell Separators
- Leuko-reduction Filters
Leukapheresis, Application Outlook (Revenue – USD Million, 2016 – 2028)
Leukapheresis, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Blood Component Providers and Blood Centers
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Transfusion Centers
Leukapheresis, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa